INM Competitors & Alternatives

Compare InMed Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

INM

Main Stock
$1.50
Tradestie Score
53
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+1233.3%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$5.03
$711.32M - 62 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 58 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$33.49
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.86
$237.15M 6.2 55 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.32
$212.23M - 57 Compare
PALI Palisade Bio, Inc. Common Stock
$1.94
$12.21M 15.3 51 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.28
$7.21M - 51 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$3.25
$4.25M - 50 Compare
REVB Revelation Biosciences, Inc. Common Stock
$1.05
$3.42M - 46 Compare
NUWE Nuwellis, Inc. Common Stock
$0.13
$2.90M - 51 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry